Endotoxin Testing Services

Introduction

Bacterial endotoxins are primarily lipopolysaccharides (LPS) from gram-negative bacteria, which are potent pyrogens that can induce systemic inflammation or septic shock. Consequently, robust detection is a non-negotiable requirement for all parenteral drugs and blood-contacting medical devices. Our endotoxin testing service helps you ensure absolute product safety and streamline your regulatory filing through advanced LAL and recombinant technologies. Creative Biolabs provides high-sensitivity quantitative analysis and sustainable testing platforms to eliminate pyrogenic risks in your biologics, medical devices, and raw materials.

Fig.1 Endotoxin enters the circulation and stimulates inflammation.¹

Standards and Guidance

The industry standards for endotoxin testing are designed to ensure that parenteral drugs and medical devices are free from bacterial pyrogens. These standards are strictly governed by regulatory bodies (USP <85>, Ph. Eur. 2.6.14, JP 4.01). In 2026, the regulatory landscape has shifted toward Quality by Design (QbD), focusing on quantitative trending and the increasing acceptance of sustainable, animal-free alternatives.

• USP <85> (United States): The primary standard for the Limulus Amebocyte Lysate (LAL) test. It defines the three main techniques: Gel-Clot, Turbidimetric, and Chromogenic.
• Ph. Eur. 2.6.14 (Europe): Harmonized with USP <85> to fully integrate recombinant factor C (rFC) as a standard, validated alternative to animal-derived LAL reagents.
• JP 4.01 (Japan): The Japanese equivalent, also harmonized under the Pharmacopeial Discussion Group (PDG).

Our Endotoxin Testing Platforms

Our endotoxin testing platform provides a comprehensive suite of solutions for detecting pyrogens, ranging from gold-standard pharmacopoeial methods to cutting-edge recombinant technologies. By offering multiple analytical pathways, we ensure compliance, sensitivity, and specificity for diverse pharmaceutical and industrial applications.

Gel-Clot LAL Assay

• We provide compliance testing using the gel-clot technique, which is often the referee method for resolving disputes or verifying simple raw material purity. It is a qualitative or semi-quantitative test used to detect the presence of endotoxins based on the formation of a firm gel.

Kinetic Chromogenic LAL Assay

• Utilizing automated microplate readers, this method measures the time to color development. It is the preferred choice for micro-sample analysis and complex biologics, offering a detection limit as low as 0.001 EU/mL, making it ideal for products that require high dilution factors.

Kinetic Turbidimetric LAL Assay

• This method monitors the increase in turbidity during the clotting protein cascade. It provides excellent stability and a broad dynamic range, making it highly efficient for large-batch sample analysis of Water for Injection (WFI), dialysis water, and common buffers.

Recombinant Factor C (rFC) Assay

• The rFC assay is accepted as a sustainable alternative to horseshoe crab-derived reagents. The assay eliminates false positives triggered by (1→3)-β-D-glucans, providing high specificity for samples containing cellulosic residues or fungal derivatives.

Workflow of our Endotoxin Testing Service

The Creative Biolabs workflow is a precision-engineered process designed to transform raw samples into high-confidence, regulatory-grade data. We prioritize transparency and scientific rigor at every stage, ensuring that potential interference is identified and mitigated before final testing begins.

Contact Us

Creative Biolabs is committed to providing the most reliable endotoxin testing service in the industry. By combining traditional LAL excellence with modern recombinant technology, we ensure your products meet every safety benchmark required for global clinical use. Contact us for detailed project discussions.